Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics

Thrombospondin-1 and VEGF in inflammatory bowel disease

(2012) Canan Alkim et al.   Libyan Journal of Medicine

Severe Spruelike Enteropathy Associated With Olmesartan

(2012) Alberto Rubio-Tapia et al.   MAYO CLINIC PROCEEDINGS

Integration of Genetic and Immunological Insights into a Model of Celiac Disease Pathogenesis

(2011) Valérie Abadie et al.   Annual Review of Immunology

Angiotensin Type 1 Receptor Blocker Reduces Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice

(2011) Xian Wu Cheng et al.   HYPERTENSION

A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects

(2011) Z. Simon-Vecsei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis

(2010) E. Myrsky et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies

(2010) Sergio Caja et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA

(2009) Essi Myrsky et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Synthesis of potent water-soluble tissue transglutaminase inhibitors

(2008) Martin Griffin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Altered small-bowel mucosal vascular network in untreated coeliac disease

(2008) Essi Myrsky et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY